da-1241
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 29, 2017 (NCT03061981)
Timeline
Indications
Mechanism of action
GPR119 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- da-1241
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06054815 | Phase 2 | Sep 14, 2023 | NeuroBo Pharmaceuticals |
| NCT03646721 | Phase 1 | Aug 29, 2018 | Dong-A Pharmaceutical |
| NCT03061981 | Phase 1 | Mar 29, 2017 | Dong-A Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dong-A Pharmaceutical | For profit | 2 | 2 | 1 | 2017 |
| NeuroBo Pharmaceuticals | For profit | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1